MedTrace Logo

EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye

NCT00637468 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2008-03-18

No results posted yet for this study

Summary

The aim of the EAGLE Study is to compare the efficacy of conservative medical treatment and local intraarterial fibrinolysis in patients with central retinal artery occlusion and to evaluate benefit and risk for the patient of both therapies.

Conditions

  • Retinal Artery Occlusion
  • Fibrinolysis
  • Visual Acuity
  • Stroke
  • Hemodilution

Interventions

DRUG

Intravenous injection of heparin

DRUG

Intravenous injection of acetazolamide

PROCEDURE

Local intra-arterial fibrinolysis

PROCEDURE

Globe massage

DRUG

Topical use of beta-blocker

DRUG

Isovolaemic haemodilution

DRUG

Acetylsalicylic acid

Sponsors & Collaborators

Principal Investigators

  • Martin Schumacher, Professor · Department of Neuroradiology, University Medical Center Freiburg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-30

Countries

  • Austria
  • Germany
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00637468 on ClinicalTrials.gov